|
US2951540A
(en)
|
1956-11-05 |
1960-09-06 |
Gen Motors Corp |
Propeller brake
|
|
US3709898A
(en)
|
1971-02-09 |
1973-01-09 |
Upjohn Co |
Process for the production of triazolobenzodiazepines and intermediates
|
|
US3681343A
(en)
|
1971-05-11 |
1972-08-01 |
Upjohn Co |
6-phenyl-s-triazolo{8 4,3-a{9 {8 1,4{9 {0 benzodiazepines
|
|
US3812259A
(en)
|
1971-08-09 |
1974-05-21 |
Upjohn Co |
Animal feed and process
|
|
CH622019A5
(en)
|
1975-10-23 |
1981-03-13 |
Upjohn Co |
Process for the preparation of aminotriazolobenzodiazepines
|
|
FR2329668A1
(fr)
|
1975-10-27 |
1977-05-27 |
Upjohn Co |
Procede de preparation d'aminotriazolobenzodiazepines
|
|
EP0087850A1
(en)
|
1982-01-04 |
1983-09-07 |
The Upjohn Company |
Benzodiazepines for anti-hypertensive use
|
|
DE3435973A1
(de)
|
1984-10-01 |
1986-04-10 |
Boehringer Ingelheim KG, 6507 Ingelheim |
Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
|
|
DE3724164A1
(de)
|
1986-07-25 |
1988-01-28 |
Boehringer Ingelheim Kg |
Neue 1,4-benzodiazepine, ihre herstellung und verwendung
|
|
DE3878833T2
(de)
|
1987-05-28 |
1993-06-09 |
Yoshitomi Pharmaceutical |
Thieno(triazolo)diazepinverbindungen, und medizinische verwendung derselben.
|
|
JPH0676326B2
(ja)
|
1988-05-24 |
1994-09-28 |
吉富製薬株式会社 |
循環器系疾患治療薬
|
|
EP0368175A1
(de)
|
1988-11-06 |
1990-05-16 |
Boehringer Ingelheim Kg |
3S,7S-3-(Morpholinocarbonyl)-5-(2-chlorphenyl)-7,10-dimethyl-3,4-dihydro-2H,7H-cyclopenta[4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin.
|
|
EP0387613A1
(de)
|
1989-03-03 |
1990-09-19 |
Boehringer Ingelheim Kg |
Neue Thienodiazepine
|
|
EP0407955A1
(de)
|
1989-07-12 |
1991-01-16 |
Boehringer Ingelheim Kg |
Neue Hetrazepine mit PAF-antagonistischer Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
DE4010528A1
(de)
|
1990-04-02 |
1991-10-17 |
Boehringer Ingelheim Kg |
Praeparativ chromatographisches trennverfahren zur herstellung enantiomerenreiner hetrazepine
|
|
EP0638560A4
(en)
|
1991-10-11 |
1995-03-29 |
Yoshitomi Pharmaceutical |
MEDICINE FOR OSTEOPOROSIS AND DIAZEPINE COMPOUND *.
|
|
WO1994006802A1
(fr)
|
1992-09-18 |
1994-03-31 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Compose de thienodiazepine et son utilisation medicinale
|
|
WO1994022872A1
(fr)
|
1993-03-30 |
1994-10-13 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Inhibiteur d'adhesion cellulaire et compose a base de thienotriazolodiazepine
|
|
WO1995026966A1
(en)
|
1994-04-01 |
1995-10-12 |
Microcide Pharmaceuticals, Inc. |
Cephalosporin antibiotics
|
|
WO1995032963A1
(en)
|
1994-06-01 |
1995-12-07 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Thienylazole compound and thienotriazolodiazepine compound
|
|
CA2209424A1
(en)
|
1995-01-06 |
1996-07-11 |
F. Hoffmann-La Roche Ag |
Hydroxymethylimidazodiazepines and their esters
|
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
|
AU725249B2
(en)
|
1995-09-09 |
2000-10-12 |
F. Hoffmann-La Roche Ag |
Use of a thienotriazolodiazepine to increase apolipoprotein A-I levels
|
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
|
AU3106197A
(en)
|
1996-06-12 |
1998-01-07 |
Japan Tobacco Inc. |
Cytokine production inhibitors, triazepine compounds, and intermediates there of
|
|
US5693641A
(en)
|
1996-08-16 |
1997-12-02 |
Berlex Laboratories Inc. |
Bicyclic pyrimidine derivatives and their use as anti-coagulants
|
|
EA001732B1
(ru)
|
1996-09-13 |
2001-08-27 |
Велфайд Корпорейшн |
Тиенотриазолодиазепиновые соединения и лекарственное средство
|
|
US6444664B1
(en)
|
1997-04-18 |
2002-09-03 |
Nederlandse Organisatie Voor Toegepast - Natuurweten Schappelijk Onderzoek (Tno) |
Method for controlling the plasma level of lipoproteins to treat alzheimeris disease
|
|
JPH11228576A
(ja)
|
1997-12-10 |
1999-08-24 |
Japan Tobacco Inc |
アポトーシス抑制剤
|
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
|
FR2779652B1
(fr)
|
1998-06-15 |
2001-06-08 |
Sod Conseils Rech Applic |
Utilisation de diazepines pour la preparation de medicaments destines a traiter les etats pathologiques ou les maladies dans lesquels un des recepteurs de la somatostatine est implique
|
|
KR20000016732A
(en)
|
1998-12-12 |
2000-03-25 |
Japan Tobacco Inc |
Cytokine production inhibitors, triazepine compounds, and intermediates thereof
|
|
US6312215B1
(en)
|
2000-02-15 |
2001-11-06 |
United Technologies Corporation |
Turbine engine windmilling brake
|
|
US7589167B2
(en)
|
2000-02-22 |
2009-09-15 |
J. David Gladstone Institutes |
ZA loops of bromodomains
|
|
WO2001095912A1
(fr)
|
2000-06-16 |
2001-12-20 |
Mitsubishi Pharma Corporation |
Compositions permettant de reguler la plage et/ou la vitesse de liberation du ph
|
|
AU2001270297A1
(en)
|
2000-06-30 |
2002-01-14 |
Neurogen Corporation |
2-phenylimidazo(1,2-a)pyridine derivatives: a new class of gaba brain receptor ligands
|
|
US20060142257A1
(en)
|
2001-01-19 |
2006-06-29 |
Eberhard Nieschlag |
Male contraceptive formulation comprising norethisterone
|
|
US6979682B2
(en)
|
2001-02-23 |
2005-12-27 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Platelet-activating factor antagonist inhibition of angiogenesis and tumor growth induced by basic fibroblast
|
|
US20030216758A1
(en)
|
2001-12-28 |
2003-11-20 |
Angiotech Pharmaceuticals, Inc. |
Coated surgical patches
|
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
|
US6861422B2
(en)
|
2003-02-26 |
2005-03-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
|
CA2515790C
(en)
|
2003-02-27 |
2012-11-27 |
Abbott Laboratories |
Heterocyclic kinase inhibitors
|
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
|
WO2005002526A2
(en)
|
2003-07-01 |
2005-01-13 |
President And Fellows Of Harvard College |
Method and compositions for treatment of viral infections
|
|
WO2005026130A1
(en)
|
2003-09-18 |
2005-03-24 |
Novartis Ag |
2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
|
|
EP1528056A1
(en)
|
2003-10-29 |
2005-05-04 |
Academisch Ziekenhuis bij de Universiteit van Amsterdam |
Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
|
|
US7759485B2
(en)
|
2004-08-14 |
2010-07-20 |
Boehringer Ingelheim International Gmbh |
Process for the manufacture of dihydropteridinones
|
|
US20060058311A1
(en)
|
2004-08-14 |
2006-03-16 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation
|
|
US20060074088A1
(en)
|
2004-08-14 |
2006-04-06 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones for the treatment of cancer diseases
|
|
US20060035903A1
(en)
|
2004-08-14 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Storage stable perfusion solution for dihydropteridinones
|
|
CN1759834B
(zh)
|
2004-09-17 |
2010-06-23 |
中国医学科学院医药生物技术研究所 |
黄连素或其与辛伐他汀联合在制备用于预防或治疗与血脂有关疾病或症状的产品中用途
|
|
WO2006129623A1
(ja)
|
2005-05-30 |
2006-12-07 |
Mitsubishi Tanabe Pharma Corporation |
チエノトリアゾロジアゼピン化合物及びその医薬としての用途
|
|
US8133900B2
(en)
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
|
US8604042B2
(en)
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
|
HUE028987T2
(en)
|
2005-11-01 |
2017-01-30 |
Targegen Inc |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
|
AR058505A1
(es)
|
2005-11-04 |
2008-02-06 |
Wyeth Corp |
Combinaciones antineoplasicas de temsirolimus y malato de sunitinib
|
|
ES2408318T3
(es)
|
2005-12-23 |
2013-06-20 |
Glaxosmithkline Llc |
Inhibidores de azaindol de las cinasas Aurora
|
|
BRPI0706560A2
(pt)
|
2006-01-17 |
2011-03-29 |
Hoffmann La Roche |
derivados de aril-isoxazol-4-il-imidazo [1,2-a] piridina úteis para o tratamento de doença de alzheimer por intermédio de receptores gaba
|
|
RU2475488C2
(ru)
|
2006-02-14 |
2013-02-20 |
Вертекс Фармасьютикалз Инкорпорейтед |
Дигидродиазепины, которые можно использовать в качестве ингибиторов протеинкиназ
|
|
US20070218135A1
(en)
|
2006-03-14 |
2007-09-20 |
Glenmark Pharmaceuticals Limited |
Sustained release matrix pharmaceutical composition
|
|
MX2008014008A
(es)
|
2006-05-03 |
2009-03-25 |
Novartis Ag |
Uso de compuestos organicos.
|
|
US7621117B2
(en)
|
2006-06-19 |
2009-11-24 |
Pratt & Whitney Canada Corp. |
Apparatus and method for controlling engine windmilling
|
|
RU2478635C2
(ru)
|
2006-10-19 |
2013-04-10 |
СИГНАЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи |
Гетероарильные соединения, содержащие их композиции и способы лечения с применением этих соединений
|
|
US7624617B2
(en)
|
2006-11-21 |
2009-12-01 |
Asml Netherlands B.V. |
Gas analyzing system, lithographic apparatus and method of improving a sensitivity of a gas analyzing system
|
|
US8338464B2
(en)
|
2006-11-30 |
2012-12-25 |
Albert Einstein College Of Medicine Of Yeshiva University |
Small molecule inhibitors of BCL6
|
|
JP2008156311A
(ja)
|
2006-12-26 |
2008-07-10 |
Institute Of Physical & Chemical Research |
Ｂｒｄ２ブロモドメイン結合剤
|
|
WO2008137081A1
(en)
|
2007-05-02 |
2008-11-13 |
The Trustees Of Columbia University In The City Of New York |
Substituted ( 5, 6 ) -dihydronaphraalenyl compounds as reversible male contraceptives
|
|
KR20080107050A
(ko)
|
2007-06-05 |
2008-12-10 |
울산대학교 산학협력단 |
항-ｃｄ１３７ 단일클론 항체를 포함하는 만성이식편대숙주 질환의 예방 또는 치료용 약학적 조성물
|
|
CA2710118A1
(en)
|
2007-12-20 |
2009-07-02 |
Cellzome Limited |
Sulfamides as zap-70 inhibitors
|
|
JP5478262B2
(ja)
|
2007-12-28 |
2014-04-23 |
田辺三菱製薬株式会社 |
抗癌剤
|
|
WO2009112490A1
(en)
|
2008-03-11 |
2009-09-17 |
Cellzome Limited |
Sulfonamides as zap-70 inhibitors
|
|
USPP20436P2
(en)
|
2008-04-10 |
2009-10-20 |
Driscoll Strawberry Associates, Inc. |
Blueberry plant named ‘DrisBlueThree’
|
|
WO2010015340A1
(en)
|
2008-08-06 |
2010-02-11 |
Bayer Schering Pharma Aktiengesellschaft |
Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment
|
|
EA018620B1
(ru)
|
2008-10-30 |
2013-09-30 |
Сёркомед Ллк |
ПРОИЗВОДНЫЕ ТИЕНОТРИАЗОЛОДИАЗЕПИНА, АКТИВНЫЕ В ОТНОШЕНИИ Apo A1
|
|
WO2010080712A2
(en)
|
2009-01-06 |
2010-07-15 |
Dana Farber Cancer Institute |
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
|
|
EP2389379A1
(en)
|
2009-01-23 |
2011-11-30 |
Takeda Pharmaceutical Company Limited |
Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
|
|
EP2488548A1
(en)
|
2009-10-14 |
2012-08-22 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung |
A low density lipoprotein-related protein 1 splice variant as cancer marker
|
|
ES2564318T3
(es)
|
2009-11-05 |
2016-03-21 |
Glaxosmithkline Llc |
Inhibidor de bromodominio de benzodiazepina
|
|
GB0919434D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919423D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
|
KR101424989B1
(ko)
|
2009-11-05 |
2014-07-31 |
글락소스미스클라인 엘엘씨 |
벤조디아제핀 브로모도메인 억제제
|
|
DE102009046518A1
(de)
|
2009-11-09 |
2011-05-12 |
Robert Bosch Gmbh |
Speicheranordnung
|
|
US20120329803A1
(en)
|
2010-02-17 |
2012-12-27 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones, method for production and use thereof
|
|
WO2011162845A1
(en)
|
2010-03-26 |
2011-12-29 |
Rolls-Royce North American Technologies, Inc. |
Adaptive fan system for a variable cycle turbofan engine
|
|
CA2799403C
(en)
|
2010-05-14 |
2020-01-21 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating leukemia
|
|
CA2799420C
(en)
*
|
2010-05-14 |
2018-10-02 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating neoplasia, inflammatory disease and other disorders
|
|
US9301962B2
(en)
|
2010-05-14 |
2016-04-05 |
Baylor College Of Medicine |
Male contraceptive compositions and methods of use
|
|
CA2799373A1
(en)
|
2010-05-14 |
2011-11-17 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating metabolism
|
|
WO2011161031A1
(en)
|
2010-06-22 |
2011-12-29 |
Glaxosmithkline Llc |
Benzotriazolodiazepine compounds inhibitors of bromodomains
|
|
US9320711B2
(en)
|
2010-06-25 |
2016-04-26 |
Shire Human Genetic Therapies, Inc. |
Methods and compositions for CNS delivery of heparan N-sulfatase
|
|
US20120014979A1
(en)
|
2010-07-16 |
2012-01-19 |
Alexander Dent |
Use of bcl6 inhibitors for treating autoimmune diseases
|
|
TWI583689B
(zh)
|
2010-08-04 |
2017-05-21 |
達納 法柏癌症學院有限公司 |
治療腫瘤形成、發炎疾病及其他病症之組成物及方法
|
|
CN107050456B
(zh)
|
2010-09-28 |
2022-08-12 |
加利福尼亚大学董事会 |
治疗代谢综合征相关疾病的gaba激动剂和治疗或预防i型糖尿病的gaba组合
|
|
US9249161B2
(en)
|
2010-12-02 |
2016-02-02 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
CN103547152A
(zh)
|
2011-02-23 |
2014-01-29 |
西奈山伊坎医学院 |
溴结构域蛋白的抑制剂作为基因表达的调节剂
|
|
EP2681216B1
(en)
|
2011-02-28 |
2017-09-27 |
Epizyme, Inc. |
Substituted 6,5-fused bicyclic heteroaryl compounds
|
|
CA2843643A1
(en)
|
2011-07-29 |
2013-02-07 |
The Children's Hospital Of Philadelphia |
Compositions and methods for the treatment of hiv
|
|
FI20110279A7
(fi)
|
2011-08-29 |
2013-03-01 |
Outotec Oyj |
Menetelmä metallien talteenottamiseksi niitä sisältävästä materiaalista
|
|
WO2013033268A2
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bivalent bromodomain ligands, and methods of using same
|
|
WO2013033269A1
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bioorthogonal monomers capable of dimerizing and targeting bromodomains and methods of using same
|
|
US10071129B2
(en)
|
2011-08-30 |
2018-09-11 |
Whitehead Institute For Biomedical Research Dana-Farber Cancer Institute, Inc. |
Method for identifying bromodomain inhibitors
|
|
DE102011082013A1
(de)
*
|
2011-09-01 |
2013-03-07 |
Bayer Pharma AG |
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
|
|
WO2013097052A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbott Laboratories |
Bromodomain inhibitors
|
|
WO2013123521A1
(en)
|
2012-02-17 |
2013-08-22 |
Nexbio, Inc. |
Methods, Compounds and Compositions for Treatment of Parainfluenza Virus in Immunocompromised Patients
|
|
EP2830629A4
(en)
|
2012-03-28 |
2016-01-20 |
Icahn School Of Medicine Mount Sinai |
COMPOSITIONS AND METHOD FOR THE REACTIVATION OF LATENT IMMUNE FIZIENZVIRUS
|
|
US9763956B2
(en)
|
2012-06-19 |
2017-09-19 |
The Broad Institute, Inc. |
Diagnostic and treatment methods in subjects having or at risk of developing resistance to cancer therapy
|
|
HK1211209A1
(en)
*
|
2012-09-28 |
2016-05-20 |
Oncoethix Gmbh |
Pharmaceutical formulation containing thienotriazolodiazepine compounds
|
|
EP2917203B1
(en)
|
2012-11-02 |
2019-04-03 |
Dana-Farber Cancer Institute, Inc. |
Method for identifying myc inhibitors
|
|
CN105164135A
(zh)
|
2013-02-22 |
2015-12-16 |
拜耳医药股份有限公司 |
4-取代的吡咯并二氮杂卓和吡唑并二氮杂卓
|
|
HK1212972A1
(zh)
|
2013-02-22 |
2016-06-24 |
Bayer Pharma Aktiengesellschaft |
作爲bet-蛋白抑制剂用於治疗过度增殖性疾病的吡咯并-和吡唑并-三唑并二氮杂卓
|
|
EP2961411A4
(en)
*
|
2013-02-28 |
2016-11-23 |
Univ Washington |
METHOD FOR TREATING INFECTIONS WITH HUMAN CYTOMAL GALOVIRUS AND DISEASES WITH BROMDOMAIN DISEASES
|
|
US9714946B2
(en)
|
2013-03-14 |
2017-07-25 |
Dana-Farber Cancer Institute, Inc. |
Bromodomain binding reagents and uses thereof
|
|
EP2968263A2
(en)
|
2013-03-15 |
2016-01-20 |
Genentech, Inc. |
Treating th2-mediated diseases by inhibition of bromodomain-comprising proteins brd7 and brd9
|
|
WO2014193951A1
(en)
|
2013-05-28 |
2014-12-04 |
Dana-Farber Cancer Institute, Inc. |
Bet inhibition therapy for heart disease
|
|
JP2016531113A
(ja)
|
2013-07-25 |
2016-10-06 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
転写因子の阻害剤およびその使用
|
|
WO2015018522A1
(en)
|
2013-08-06 |
2015-02-12 |
Oncoethix Sa |
Bet-bromodomain inhibitor shows synergism with several anti-cancer agents in pre-clinical models of diffuse large b-cell lymphoma (dlbcl)
|
|
WO2015018521A1
(en)
|
2013-08-06 |
2015-02-12 |
Oncoethix Sa |
Method of treating diffuse large b-cell lymphoma (dlbcl) using a bet-bromodomain inhibitor
|
|
EP3033423A4
(en)
|
2013-08-16 |
2017-04-26 |
Rana Therapeutics Inc. |
Epigenetic regulators of frataxin
|
|
WO2015042249A1
(en)
|
2013-09-19 |
2015-03-26 |
Dana-Farber Cancer Institute, Inc. |
Methods of bh3 profiling
|
|
AU2014331697A1
(en)
|
2013-10-11 |
2016-05-05 |
Constellation Pharmaceuticals, Inc. |
Use of CBP/EP300 bromodomain inhibitors for cancer immunotherapy
|
|
MX379463B
(es)
|
2013-11-08 |
2025-03-10 |
Dana Farber Cancer Inst Inc |
Terapia de combinación para el cáncer usando inhibidores de la proteína bromodominio y extra-terminal.
|
|
WO2015081284A1
(en)
|
2013-11-26 |
2015-06-04 |
Coferon, Inc. |
Bivalent bromodomain ligands, and methods of using same
|
|
RU2016134941A
(ru)
|
2014-01-31 |
2018-03-01 |
Дана-Фарбер Кансер Институт, Инк. |
Производные диазепана и их применения
|
|
WO2015117087A1
(en)
|
2014-01-31 |
2015-08-06 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
|
MX2016009974A
(es)
|
2014-01-31 |
2016-10-31 |
Dana Farber Cancer Inst Inc |
Derivados de diaminopirimidina bencensulfona y sus usos.
|
|
RU2722179C2
(ru)
|
2014-02-28 |
2020-05-28 |
Тэнша Терапеутикс, Инк. |
Лечение состояний, ассоциированных с гиперинсулинемией
|
|
BR112017008714A2
(pt)
|
2014-10-27 |
2017-12-19 |
Tensha Therapeutics Inc |
inibidores de bromodomínio
|
|
SG11201704089UA
(en)
|
2014-12-05 |
2017-06-29 |
H Lee Moffitt Cancer Ct & Res |
Bromodomain inhibitor as adjuvant in cancer immunotherapy
|
|
HK1252062A1
(zh)
|
2015-06-26 |
2019-05-10 |
腾沙治疗公司 |
Nut中线癌的治疗
|
|
BR112018006689A2
(pt)
|
2015-10-02 |
2018-10-09 |
Dana Farber Cancer Inst Inc |
terapia de combinação de inibidores de bromodomínio e bloqueio de ponto de controle
|